Arcturus Therapeutics
ARCT
ARCT
19 hedge funds and large institutions have $7.87M invested in Arcturus Therapeutics in 2017 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
54% less call options, than puts
Call options by funds: $45K | Put options by funds: $98K
Holders
19
Holding in Top 10
–
Calls
$45K
Puts
$98K
Top Buyers
| 1 | +$610K | |
| 2 | +$156K | |
| 3 | +$104K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$95K |
| 5 |
VF
Virtu Financial
New York
|
+$86K |
Top Sellers
| 1 | -$812K | |
| 2 | -$276K | |
| 3 | -$236K | |
| 4 |
KCM
Kingdon Capital Management
New York
|
-$114K |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$52K |